Payer PolicyActive
Autologous Cellular Therapy – Commercial and Individual Exchange Medical Policyopen_in_new
UHC-POL-autologous-cellular-therapy
UnitedHealthcare
Effective: October 1, 2025
Updated: December 6, 2025
created · Nov 30, 2025
Policy Summary
Autologous cellular therapy is considered unproven and not medically necessary for all indications and therefore excluded from routine coverage. Coverage decisions must follow the member-specific benefit plan (and applicable federal/state mandates) — CPT codes listed are for reference only and do not imply coverage while efficacy and long‑term safety remain unestablished.
Coverage Criteria Preview
Key requirements from the full policy
"No covered indications are specified. (Coverage Rationale: "Autologous Cellular Therapy is unproven and not medically necessary for all indications due to insufficient evidence of efficacy."
Sign up to see full coverage criteria, indications, and limitations.